Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor alpha therapy.

about

Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor alpha therapy.

Item

http://www.wikidata.org/entity/Q47561508

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Progression of undiagnosed cut ...... necrosis factor alpha therapy.

@en

Progression of undiagnosed cut ...... necrosis factor alpha therapy.

@nl

type

Item

label

Progression of undiagnosed cut ...... necrosis factor alpha therapy.

@en

Progression of undiagnosed cut ...... necrosis factor alpha therapy.

@nl

prefLabel

Progression of undiagnosed cut ...... necrosis factor alpha therapy.

@en

Progression of undiagnosed cut ...... necrosis factor alpha therapy.

@nl

P1476

Progression of undiagnosed cut ...... necrosis factor alpha therapy.

@en

P2093

Alba L Posligua

http://www.w3.org/2001/XMLSchema#string

Audrey Rutherford

http://www.w3.org/2001/XMLSchema#string

Barbara Pro

http://www.w3.org/2001/XMLSchema#string

Belen Rubio-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Christiane Querfeld

http://www.w3.org/2001/XMLSchema#string

Heather Wickless

http://www.w3.org/2001/XMLSchema#string

Jason B Kaplan

http://www.w3.org/2001/XMLSchema#string

Joan Guitart

http://www.w3.org/2001/XMLSchema#string

Kimberly A Sable

http://www.w3.org/2001/XMLSchema#string

Maria Estela Martinez-Escala

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.

Erythroderma in the era of biological therapies.

CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab.

Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab

The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network

Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.

Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis.

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.

P304

1068-1076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAAD.2017.12.068

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jaehyuk Choi

Xiaolong Zhou

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29307643

http://www.w3.org/2001/XMLSchema#string

P932

5951749

http://www.w3.org/2001/XMLSchema#string